Literature DB >> 2259260

[Prognostically relevant factors in follicular thyroid cancer].

T Böttger1, J Klupp, K Sorger, T Junginger.   

Abstract

The discussion of the prognosis of follicular thyroid carcinoma is controversial. To evaluate the factors which influence the prognosis we retrospectively analyzed our patients from 1. 1. 1964 to 31. 12. 1987. 76 patients with a follicular thyroid carcinoma were treated during this time. Factors influencing the prognosis were: (1) multiple tumor growth; (2) pT-classification; (3) vascular invasion; (4) tumor stage; (5) degree of cellular differentiation and (6) metastases. Because of the prognostic influence of multiple tumor growth and the slight prognostic influence of lymph node metastases we recommend a total thyroidectomy with neck dissection for follicular thyroid carcinoma.

Entities:  

Mesh:

Year:  1990        PMID: 2259260

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  23 in total

1.  Deaths due to differentiated thyroid cancer: a 46-year perspective.

Authors:  J K Harness; M K McLeod; N W Thompson; W C Noble; R E Burney
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

Review 2.  Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment.

Authors:  E L Mazzaferri
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

3.  Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.

Authors:  I D Hay; C S Grant; W F Taylor; W M McConahey
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

4.  Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma.

Authors:  B Cady; C E Sedgwick; W A Meissner; J R Bookwalter; V Romagosa; J Werber
Journal:  Ann Surg       Date:  1976-11       Impact factor: 12.969

5.  Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.

Authors:  J Tennvall; A Biörklund; T Möller; J Ranstam; M Akerman
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

6.  Follicular carcinoma of the thyroid gland: trends and treatment.

Authors:  J K Harness; N W Thompson; M K McLeod; F E Eckhauser; R V Lloyd
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

7.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

8.  Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age.

Authors:  F Bacourt; B Asselain; J C Savoie; E D'Hubert; J P Massin; G Doucet; A Leger; H Garnier
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

9.  Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi; M Silverman; M Wool
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

10.  Prognostic factors in thyroid tumours.

Authors:  D J Kerr; A D Burt; P Boyle; G J MacFarlane; A M Storer; T B Brewin
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more
  2 in total

1.  Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.

Authors:  Jürgen Witte; Steffen Lehmann; Michael Wulfert; Quin Yang; Hans D Röher
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

2.  Follicular tumors of the thyroid gland: diagnosis, clinical aspects and nuclear DNA analysis.

Authors:  J Zedenius; G Auer; M Bäckdahl; U Falkmer; L Grimelius; G Lundell; G Wallin
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.